Last reviewed · How we verify
NCT06230926
Turkish Adaptation of "Parkinson's Disease Quality of Life 7 (PDQoL7)" Questionnaire
trial testing Validity, Reliability and Adaptation in Parkinson Disease in 129 participants. Completed in 11 November 2025.
11 November 2025
Quick facts
| Lead sponsor | Nigde Omer Halisdemir University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 129 |
| Start date | 11 November 2023 |
| Primary completion | 11 November 2025 |
| Estimated completion | 11 November 2025 |
| Sites | 3 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Validity, Reliability and Adaptation
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Nigde Omer Halisdemir University
Who can join
18 and older, any sex, with Parkinson Disease or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the involvement of dopaminergic pathways in the basal ganglia. Motor and non-motor symptoms are frequently observed in PD. These symptoms may negatively affect the quality of life of individuals with PD. Therefore, it is recommended to evaluate the quality of life of individuals with PD and plan appropriate treatments. The "Parkinson's Disease Quality of Life 7 (PDQoL7)" questionnaire is a patient-reported quality of life assessment questionnaire developed specifically for individuals with PD. The questionnaire, which consists of 7 questions in total, evaluates the degree of difficulty the patient has in performing various activities. The aim of this study was to adapt the PDQoL7 questionnaire into Turkish and to establish its validity and reliability.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychometric properties of the Turkish version of the Parkinson's disease quality of life-7 (PDQoL-7) in older adults.
Demirtaş A, İşcan D, Kardiyen F, Suiçmez S, et al · · 2026 · PMID 41975301 · DOI 10.1186/s12877-026-07458-y
Verify or expand the search:
- PubMed search for NCT06230926
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Validity, Reliability and Adaptation
Trials testing the same drug.
- NCT06231030 — Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) Turkish Adaptation · unknown
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Nigde Omer Halisdemir University trials
Trials by the same sponsor.
- NCT07392619 — The Effect of Acupressure on Symptoms in Elderly Adults With Painful Diabetic Neuropathy · NA · not yet recruiting
- NCT07525726 — The Relationship Between Finger Ratio and Development in Infants · enrolling by invitation
- NCT07468981 — Movement Quality and Mechanical Properties of the Muscle · active not recruiting
- NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting
- NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06230926 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nigde Omer Halisdemir University
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06230926.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing